| Dr Mohsen Khoshneviszadeh, DPM | |
|
2400 Mount Zion Pkwy, Southwood Medical Center - Dept Of Podiatry, Jonesboro, GA 30236-2500 | |
| (770) 603-3547 | |
| Not Available |
| Full Name | Dr Mohsen Khoshneviszadeh |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 25 Years |
| Location | 2400 Mount Zion Pkwy, Jonesboro, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376564971 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | POD001005 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Southeast Permanente Medical Group | 6204829013 | 576 |
News Archive
Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has entered into a research collaboration agreement with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) for the development of a plant-based VLP vaccine candidate for the prevention of Ebola. Ebola is a very serious hemorrhagic fever virus for which no licensed treatment or vaccine exists.
According to the American Cancer Society, pancreatic cancer is the fourth leading cancer killer in the country, with more than 42,000 new cases expected to be diagnosed this year and more than 35,000 deaths. In New Jersey alone, 1,000 deaths are estimated from the disease, which only has a five-year, five-percent survival rate.
Neuroscientists and engineers at UCSF and UC Berkeley have joined forces to help pioneer a new frontier of brain repair - the development of devices that would allow patients with such conditions as stroke, spinal cord injury, traumatic brain injury and Lou Gehrig's disease to control prosthetics through thoughts alone.
Encorium Group, Inc., a full service multinational clinical research organization conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced its financial results for the fourth quarter and year ended December 31, 2009.
"There is no option when it comes to reforming America's ailing healthcare system. We must do it. And there is no option for inclusion of a public plan. We must have it. Real reform requires real choice. A public option provides consumers a critical alternative to private plans.
› Verified 5 days ago
| Provider Name | The Southeast Permanente Medical Group |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1245266956 PECOS PAC ID: 6204829013 Enrollment ID: O20040407000370 |
News Archive
Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has entered into a research collaboration agreement with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) for the development of a plant-based VLP vaccine candidate for the prevention of Ebola. Ebola is a very serious hemorrhagic fever virus for which no licensed treatment or vaccine exists.
According to the American Cancer Society, pancreatic cancer is the fourth leading cancer killer in the country, with more than 42,000 new cases expected to be diagnosed this year and more than 35,000 deaths. In New Jersey alone, 1,000 deaths are estimated from the disease, which only has a five-year, five-percent survival rate.
Neuroscientists and engineers at UCSF and UC Berkeley have joined forces to help pioneer a new frontier of brain repair - the development of devices that would allow patients with such conditions as stroke, spinal cord injury, traumatic brain injury and Lou Gehrig's disease to control prosthetics through thoughts alone.
Encorium Group, Inc., a full service multinational clinical research organization conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced its financial results for the fourth quarter and year ended December 31, 2009.
"There is no option when it comes to reforming America's ailing healthcare system. We must do it. And there is no option for inclusion of a public plan. We must have it. Real reform requires real choice. A public option provides consumers a critical alternative to private plans.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mohsen Khoshneviszadeh, DPM 2710 Margaret Mitchell Dr Nw, Atlanta, GA 30327-1841 Ph: (404) 549-9345 | Dr Mohsen Khoshneviszadeh, DPM 2400 Mount Zion Pkwy, Southwood Medical Center - Dept Of Podiatry, Jonesboro, GA 30236-2500 Ph: (770) 603-3547 |
News Archive
Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has entered into a research collaboration agreement with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) for the development of a plant-based VLP vaccine candidate for the prevention of Ebola. Ebola is a very serious hemorrhagic fever virus for which no licensed treatment or vaccine exists.
According to the American Cancer Society, pancreatic cancer is the fourth leading cancer killer in the country, with more than 42,000 new cases expected to be diagnosed this year and more than 35,000 deaths. In New Jersey alone, 1,000 deaths are estimated from the disease, which only has a five-year, five-percent survival rate.
Neuroscientists and engineers at UCSF and UC Berkeley have joined forces to help pioneer a new frontier of brain repair - the development of devices that would allow patients with such conditions as stroke, spinal cord injury, traumatic brain injury and Lou Gehrig's disease to control prosthetics through thoughts alone.
Encorium Group, Inc., a full service multinational clinical research organization conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced its financial results for the fourth quarter and year ended December 31, 2009.
"There is no option when it comes to reforming America's ailing healthcare system. We must do it. And there is no option for inclusion of a public plan. We must have it. Real reform requires real choice. A public option provides consumers a critical alternative to private plans.
› Verified 5 days ago
Kalish Foot & Ankle Institute Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 6911 Tara Blvd Ste 101, Jonesboro, GA 30236 Phone: 770-477-9535 | |
Dr. Jaclyn Marie Schwartz, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2400 Mount Zion Pkwy, Kaiser Permanente Southwood Comprehensive Medical Cente, Jonesboro, GA 30236 Phone: 770-663-8011 Fax: 770-754-9820 | |
Mr. Vinay Kumar Matai, D.P.M Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2400 Mount Zion Pkwy, Jonesboro, GA 30236 Phone: 770-603-3575 | |
Dr. Azuka Ifeyinwa Nwaedozie, D.P.M Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3364 Medina Dr, Jonesboro, GA 30236 Phone: 678-489-6589 Fax: 678-489-6522 | |
Clayton Mobile Diagnostic Clinic Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 6911 Tara Blvd, Jonesboro, GA 30236 Phone: 770-477-9535 Fax: 770-471-7826 | |
Atlanta Foot And Leg Clinic Podiatrist Medicare: Medicare Enrolled Practice Location: 6911 Tara Blvd, Suite 101, Jonesboro, GA 30236 Phone: 770-477-9535 Fax: 770-471-7826 |